O-GlcNAcylation is a reversible type of serine/threonine glycosylation on nucleocytoplasmic proteins in metazoa. Various genetic approaches in several animal models have revealed that O-GlcNAcylation is essential for embryogenesis. However, the dynamic changes in global O-GlcNAcylation and the underlying mechanistic biology linking them to embryonic development is not understood. One of the limiting factors towards characterizing changes in O-GlcNAcylation has been the limited specificity of currently available tools to detect this modification. In the present study, harnessing the unusual properties of an O-GlcNAcase (OGA) mutant that binds O-GlcNAc (O-Nacetylglucosamine) sites with nanomolar affinity, we uncover changes in protein O-GlcNAcylation as a function of Drosophila development.
INTRODUCTION
Protein O-GlcNAcylation is a dynamic nucleocytoplasmic posttranslational modification (PTM) involving the transfer of Nacetylglucosamine (GlcNAc) to protein serine/threonine residues [1] . O-GlcNAc transfer is catalysed by O-GlcNAc transferase (OGT) and its removal is catalysed by O-GlcNAcase (OGA) [1] . OGT and OGA are both encoded by single genes in most animals, building an O-GlcNAc proteome of over 1000 proteins involved in metabolic pathways, cell signalling, transcriptional and translational control, epigenetic modification, intracellular trafficking and as components of nuclear pores [2] . Disruption of O-GlcNAc signalling is associated with pathogenesis, including diabetes, cancer and nervous system disorders [3] [4] [5] . Utilizing several genetic approaches, it has been demonstrated that OGlcNAcylation is essential for embryonic development in mouse, Drosophila and zebrafish [6] [7] [8] , although the underpinning mechanistic biology remains to be explored. Drosophila contains single copies of both OGT [also known as super sex combs (sxc)] and OGA. sxc mutants do not survive beyond the pupal stages, whereas a mutant lacking OGA protein is viable [7, 9] . Although sxc is known to be essential for Drosophila development, changes in the O-GlcNAc proteome as a function of embryonic development have not yet been characterized.
Although the O-GlcNAc PTM was discovered three decades ago, its detection and quantification remains challenging. One of the pan-O-GlcNAc antibodies, CTD110.6, is a mouse monoclonal IgM raised against an O-GlcNAcylated peptide derived from the C-terminal domain of RNA polymerase II [10] . However, CTD110.6 has been shown to cross-react with N-glycosylated proteins [11, 12] , GlcNAc in the endoplasmic reticulum [13] and extracellular O-GlcNAc proteins [14, 15] . The other commercially available O-GlcNAc antibody, RL2, shows selectivity towards glycosylated nucleoporins [16] . Other methods to detect nucleocytoplasmic O-GlcNAc include labelling with (UDP)- [ 3 H]galactose using galactosyltransferase [17] , lectins [18] , chemical labelling with modified galactose and recombinant galactosyltransferase [19] [20] [21] and 35 S-labelling using GlcNAcspecific sulfotransferases [22] . These techniques recognize only a subset of the O-GlcNAc proteome and/or are not compatible with more complex biological samples.
The bacterium Clostridium perfringens possesses an apparent OGA orthologue (CpOGA) of unknown function, but with a remarkable ability to strip entire O-GlcNAc proteomes of OGlcNAc [23, 24] . Interestingly, when a critical catalytic residue (Asp 298 , the catalytic acid protonating the glycosidic bond) is mutated to asparagine (CpOGA D298N ), catalytic activity is lost, yet substrate binding is retained [23] . This has been exploited to determine crystal structures of Ser-O-GlcNAc peptides in complex with CpOGA [25] . In the present study, we investigate the hypothesis that CpOGA D298N can also specifically bind to OGlcNAcylated proteins and thus be used in a far-Western approach ( Figure 1a ) to reveal changes in protein O-GlcNAcylation as a function of Drosophila embryonic development.
MATERIALS AND METHODS

Protein production
pGEX6P1 plasmids containing N-terminally GST-tagged CpOGA WT (31-618) [25] and mutants were transformed into Escherichia coli BL21(DE3) pLysS cells. Cells were grown Abbreviations: ACN, acetonitrile; ConA, concanavalin A; CpOGA, Clostridium perfringens OGA orthologue; dHCF, Drosophila host cell factor; DmOGT, Drosophila OGT; ETD, electron transfer dissociation; GalNAz, N-azidoacetylgalactosamine; GlcNAc, N-acetylglucosamine; Fmoc, 9-fluorenylmethyloxycarbonyl; HA, haemagglutinin; HCF, host cell factor; HEK, human embryonic kidney; hOGA, human OGA; LB-Amp, LB medium containing 50 μg/ml ampicillin; OGA, O-GlcNAcase; OGT, O-GlcNAc transferase; Ph, polyhomoeotic; PNGase F, peptide: N-glycosylase F; PTM, posttranslational modification; SPR, surface plasmon resonance; sxc, super sex combs; TAB1, transforming growth factor-beta-activated protein kinase 1-binding protein 1; TFA, trifluoroacetic acid. 1 These authors contributed equally to this work. 2 To whom correspondence should be addressed (email dmfvanaalten@dundee.ac.uk). overnight at 37
• C in LB medium containing 50 μg/ml ampicillin (LB-Amp) and used at 10 ml/l to inoculate fresh LB-Amp. Cells were grown to an OD 600 of 0.6-0.8, transferred to 18
• C and induced with 250 μM isopropyl beta-D-1-thiogalactopyranoside (IPTG) and harvested after 16 h by centrifugation for 30 min at 2000 g (4
• C). Cell pellets were resuspended in 10-20 ml/l of 50 mM Tris/HCl and 250 mM NaCl at pH 7.5 (lysis buffer) supplemented with protease inhibitors (1 mM benzamidine, 0.2 mM phenylmethylsulfonyl fluoride (PMSF) and 5 μM leupeptin), DNAse and lysozyme prior to lysis. Cells were lysed using a continuous flow cell disrupter (Avestin, three passes at 20 kpsi; 1 psi = 6.9 kPa) and the lysate was cleared by centrifugation (30 min, 48 000 g, 4
• C). Supernatants were collected and loaded on to 2 ml of glutathione-Sepharose (GE Healthcare Life Sciences) pre-equilibrated with lysis buffer. The column was washed with 500 ml of lysis buffer. Proteins were eluted with 25 ml of lysis buffer supplemented with 50 mM reduced glutathione and dialysed into 1× tris buffered saline (TBS), pH 7.5. Proteins were further purified by size-exclusion chromatography using a Superdex 200, 26/60 column. transforming growth factor-beta-activated protein kinase 1-binding protein 1 (TAB1) was purified as described previously [26] .
Synthesis of peptides and fluorescently labelled GlcNAcstatin
The glycosylated amino acid building blocks 3,4,6-triacetyl-O-GlcNAc-Fmoc-Ser-OH and 3,4,6-triacetyl-O-GlcNAc-FmocThr-OH were synthesized in-house according to the published procedures [25] . Microwave-assisted solid-phase peptide synthesis was performed with a CEM Liberty automated peptide synthesizer on low-load (0.38 mmol/g) Rink amide 4-methylbenzhydrylamine (MBHA) resin 100-200 mesh (Novabiochem) using standard 9-fluorenylmethyloxycarbonyl (Fmoc) chemistry protocols on a 0.05 mmol scale. After the removal of the N-terminal Fmoc group the peptidyl resin was acetylated (acetic anhydride, N,N-Diisopropylethylamine), carbohydrate residues were deprotected (20 % hydrazine, methanol) and peptides were globally deprotected and cleaved from the resin with trifluoroacetic acid (TFA)/triisopropylsilane (TIPS)/water (92.5:2.5:5, by vol.) cocktail for 2 h. The cleavage mixture was filtered off, the resin was washed with TFA twice and the combined filtrate was concentrated to one-tenth of the initial volume in vacuum. The oily residue was triturated with cold (0 • C) methyl t-butyl ether and the precipitated peptide was collected by centrifugation. The crude peptides were purified to more than 95 % purity using Waters Peptide Separation Technology 19 mm×100 mm C 18 column at a flow rate 20 ml/min, on a preparative HPLC system consisting of Gilson 331/332 pumps, Gilson UV156 detector and Gilson 203 fraction collector controlled by Gilson Trilution LC software. The appropriate fractions were pooled and freeze-dried.
Synthesis of the FITC-labelled fluorescence polarization probe was based on the synthetic procedure for GlcNAcstatin B [27] and details are available on request from D.M.F.v.A.
Protein crystallography
CpOGA
D298N was purified and crystallized as described previously [25] . The glycopeptide complex with Drosophila host cell factor (dHCF) (VPSgTMSAN) peptide was achieved through soaking with 10 mM glycopeptide for 0.5 h prior to cryoprotection with 20 % glycerol in mother liquor. Diffraction data were collected at the Diamond Light Source (Didcot) I03 (Supplementary Table  S1 ). Crystals belonged to space group P6 1 and contained one molecule per asymmetric unit, with 73.47 % solvent content. The structure was solved by molecular replacement, using PDB code 2YDS [25] as a search model, followed by iterative model building with COOT [28] and refinement with REFMAC5 [29] using 2 % of reflections as an R free test set. Supplementary Table S1 gives details of the data collection, processing and refinement statistics. The model for the peptide was included when it became fully defined by the difference map upon refining the protein structure and adding hetero atoms. The occupancy for the peptide was set at 0.75.
Surface plasmon resonance
CpOGA
WT (31-618) and mutants were purified as described previously [25] . Proteins were chemically biotinylated using the EZ-Link NHS-PEG4-Biotin kit (Thermo) according to the manufacturer's instructions, except that a 1:1 molar ratio of biotinylation reagent to protein was used. Proteins were captured on a neutravidin surface prepared on high-capacity amine sensor chip of a Mass-1 instrument (Sierra Sensors) at densities ∼3600-3900 RU (relative units). All experiments were performed at 25
• C. Ligands were injected over captured proteins at flow rate of 30 μl/min in running buffer (50 mM HEPES, 250 mM NaCl, 10 mM EDTA, 5 mM tris (2-carboxyethyl) phosphine (TCEP) and, 0.05 % Tween 20, with each compound injected in duplicate in concentration series adjusted specifically around their affinities. Association was measured for 60 s and dissociation for 120 s. All data were double referenced for blank injections of buffer and biotin-blocked streptavidin surface. Analyser 2 (Sierra Sensors) and Scrubber 2 (BioLogic Software) were used to process and analyse the data.
Fluorescence polarization
Experiments were performed in PerkinElmer black 384-well plates and millipolarization units were measured using a Pherastar FS plate reader (BMG LABTECH) at excitation and emission wavelengths of 485 nm and 520 nm respectively. For determination of the equilibrium dissociation constant (K d ) of CpOGA D298N for the fluorescent probe, 5 nM probe was incubated with a range of concentrations of protein in 25 μl of total reaction volume containing 1× TBS buffer, pH 7.5, and a final concentration of 1 % dimethyl sulfoxide (DMSO). Reactions were allowed to stand at room temperature for 10 min and polarization was measured every 5 min for a period of 2.5 h (equilibrium was reached within 10 min). Readings were corrected for background emissions from reactions containing no CpOGA D298N and K d was determined by fitting a non-linear regression curve with Prism (GraphPad) to readings obtained at 15 min. To avoid receptor depletion, reaction mixtures for competition binding experiments contained 5 nM fluorescent probe, 20 nM CpOGA D298N (receptor) and a range of concentrations of O-GlcNAcylated peptides under the aforementioned reaction conditions. The highest amount of fluorescent probe bound to CpOGA D298N in the absence of competing O-GlcNAcylated peptides was arbitrarily set as 100 %. EC 50 values were determined by fitting non-linear regression curves with Prism (GraphPad) and converted into K d as described elsewhere [30] . All experiments were performed in triplicate.
Drosophila stocks and embryo collections
w1118 wild-type flies were used for all experiments. Embryos were collected on apple juice agar plates at 25
• C for 30 min and aged for an additional 2, 4.5, 10.5 or 14.5 h. To make total embryo lysates, overnight (0-16 h) embryo collections were set up. The embryos thus collected and aged were dechorionated with bleach and snap frozen on dry ice. Other lines used were UAS::OGT WT -HA (haemagglutinin) and tub::GAL4/TM3. To overexpress HAtagged OGT WT , UAS::OGT WT -HA homozygous virgins were crossed with tub::GAL4/TM3 flies and 0-16 h embryos were collected on apple juice agar plates, dechorionated with bleach and used for immunoprecipitation experiments.
Lysates and immunoprecipitation
Drosophila embryo, human embryonic kidney (HEK)293 and S2 cell lysates were prepared identically for Western blot, farWestern blot and immunoprecipitation experiments. The frozen embryos were homogenized in lysis buffer (50 mM Tris/HCl, pH 8.0, 150 mM NaCl, 1 % Triton-X-100, 1 μM GlcNAcstatin C, 5 mM sodium fluoride, 2 mM sodium orthovanadate, 1 mM benzamidine, 0.2 mM PMSF, 5 μM leupeptin and 1 mM DTT). Confluent HEK293 or S2 cultures were washed with 1× PBS, pH 7.5, prior to lysis with lysis buffer. Lysates were then centrifuged at 16 000 g for 10 min, supernatants were collected and protein concentrations were estimated using the 660 nm protein assay (Thermo Scientific).
For immunoprecipitation experiments, lysates of OGT WT -HA-overexpressing embryos were prepared with lysis buffer and 2.5 mg protein was incubated with Protein G-Dynabeads (Invitrogen) bound to 5 μg of anti-HA antibody (clone 12CA5). For immunoprecipitating O-GlcNAcylated proteins, 5 mg of S2 cell lysate was incubated with Protein G-Dynabeads bound to 10 μg of anti-O-GlcNAc antibody (RL2). After washing, the immunoprecipitated proteins were eluted by boiling with 1× SDS loading buffer. The proteins were then separated on 4-12 % NuPAGE gels, stained with Coomassie Blue, and gel pieces at the same molecular mass range in the control IgG and RL2 immunoprecipitates were excised and processed for mass spectrometry (MS). Where indicated, the immunoprecipitate, after washing away the lysate, was incubated with 10 μg of CpOGA for 60 min at 30
• C.
Mass spectrometry (MS)
The excised gel pieces were subjected to enzymatic digestion as previously reported with minor modifications [31] . Briefly, excised bands were rinsed thrice with AmBic buffer [50 mM ammonium bicarbonate in 50 % methanol (HPLC grade, Merck)] followed by a reduction step with 10 mM DTT (SigmaAldrich). Subsequently, the gel pieces were rinsed twice with AmBic buffer and dried in a SpeedVac before alkylation with 55 mM iodoacetamide (Sigma-Aldrich) in 50 mM ammonium bicarbonate. Thereafter, the gel pieces were rinsed with AmBic buffer, dehydrated with acetonitrile (ACN; HPLC grade, Merck) and dried in a SpeedVac. The dry gel pieces were treated with trypsin (Promega; 20 ng/μl in 20 mM ammonium bicarbonate), incubating them at 37
• C for 16 h. Peptides were extracted thrice by incubating for 20 min with 40 μl of 60 % ACN in 0.5 % formic acid. The resulting peptide extracts were pooled, concentrated in a SpeedVac and stored at − 20
• C until MS analysis. Identification of the O-GlcNAcylated proteins and O-GlcNAc sites was performed by ESI-IT (ion trap)-ETD (electron transfer dissociation) MS coupled to a nano-LC system (Ultimate 3000 RSLC, Dionex). Dried peptides were resuspended in 30 μl of 0.5 % formic acid and 10 μl of this was injected for mass spectrometric analysis. Tryptic peptides were concentrated on a trap column (2 cm×100 μm, Dionex) at 10 μl/min and separated on a 15 cm×75 μm Pepmap C 18 reversed-phase column (Thermo Fisher Scientific). Peptides were eluted by a linear 60 min gradient of 95 % A/5 % B to 10 % A/90 % B (A: water, 0.1 % formic acid; B; 80 % ACN, 0.08 % formic acid) at 300 nl/min into a LTQ Velos ETD (Thermo Fisher Scientific). MS spectra were acquired in positive mode; first MS full scans were acquired followed by MS/MS in ETD mode. Up to ten most intense precursors were selected for ETD fragmentation with an activation time of 300 ms and non-dynamic exclusion. Proteome Discoverer version 1.4.0.288 software (Thermo Scientific) was used to process raw LC-MS/MS data, applying the Mascot (version 2.4, Matrix Science) search engine algorithm against SwissProt database with specified taxonomy (Drosophila melanogaster, number of sequences 5545) with the following Mascot parameters: 2+, 3+, 4+ and 5+ ions; precursor mass tolerance 100 ppm; fragment tolerance 0.6 Da and up to two missed cleavages. The variable modifications included were: oxidation (M; 15.99 Da), dioxidation (M; + 31.98 Da) and HexNAc (ST; + 203.0794 Da). All MS/MS data and database results were manually inspected in detail to verify the automatic assignment of fragment ions using the above software.
Western and far-Western blot analysis
Ten micrograms of the crude lysates was subjected to SDS/PAGE and transferred on to a nitrocellulose membrane before immunoblotting with 1 μg/ml RL2 (1:1000 dilution of 1 mg/ml, Abcam), 0.6 μg/ml CTD110.6 (1:500 dilution of 0.3 mg/ml, Cell Signaling Technologies), mouse anti-α-tubulin (1:10 000 dilution, Developmental Studies Hybridoma Bank), rabbit anti-tubulin (1:2500 dilution, Cell Signalling) and/or rabbit anti-actin (1:5000 dilution, Sigma). For the far-Western blot experiments, the blots were incubated with 10 μg/ml GSTCpOGA D298N for 30 min at room temperature followed by incubation with sheep anti-GST (1:5000 dilution) antibody. For each of the experiments, the respective IR dye-conjugated secondary antibodies or IR dye-conjugated streptavidin (LiCor or Life Technologies, 1:10 000 dilution) were used. Signal was detected with an Odyssey ® Li-Cor IR imaging system. Labelling with UDP-N-azidoacetylgalactosamine (GalNAz) and biotinylation of the labelled proteins was performed using Click-IT O-GlcNAc enzymatic labelling system and the Click-IT Biotin protein analysis system (Life Technologies). To ascertain the specificity of the O-GlcNAc signal, embryo lysates (made without GlcNAcstatin C) were pre-treated with 10 μg of CpOGA for 60 min at 30
• C before being processed. Control samples not treated with CpOGA were also incubated at 30
• C for 60 min. To establish that CpOGA D298N does not cross react with Nglycosylated proteins, lysates were treated with peptide: Nglycosidase F (PNGase F) (NEB) as per the manufacturer's instructions. Removal of N-glycans was monitored by blotting with a specific lectin, concanavalin A (ConA), following a previously described protocol [32] .
RESULTS AND DISCUSSION
Since the Drosophila O-GlcNAc proteome has not previously been studied, we initially immunoprecipitated O-GlcNAc proteins from Drosophila S2 cell lysates using the anti-O-GlcNAc RL2 antibody and analysed these with ETD MS/MS. Several peptides from dHCF were found to be O-GlcNAcylated with one site conserved with the human HCF1 orthologue (Supplementary Figure S1 , V 614 PSgTMSAN 621 ). Human HCF1 is one of the best-characterized OGT substrates that is heavily glycosylated and proteolytically cleaved by OGT, known to play a central role in epigenetic regulation of gene expression [33, 34] . We next investigated whether the dHCF Thr-O-GlcNAc peptide V 614 PSgTMSAN 621 , containing an O-GlcNAcylated threonine residue, was able to bind CpOGA D298N . To facilitate this, we developed a fluorescence polarization assay based on a newly synthesized FITC-labelled OGA inhibitor that binds with 15 nM affinity to CpOGA D298N (Figure 1b) . In competition experiments, the dHCF O-GlcNAc peptide was shown to bind CpOGA Figure S2) . To explore the molecular basis of these interactions and possible differences in recognition of Ser-compared with Thr-O-GlcNAc proteins, we determined the crystal structure of CpOGA D298N in complex with the dHCF-derived peptide (Figure 1d ). The structure reveals tight contacts between the GlcNAc moiety and the protein via hydrogen bonds to residues that are all conserved in hOGA and explains why binding is lost with the D401A mutant of the enzyme (CpOGA D401A ), which abrogates the interactions with the GlcNAc O4 and O6 hydroxy groups [23] . Furthermore, Tyr 189 , conserved in hOGA, makes stacking interactions with the backbone of the O-GlcNAc peptide, explaining how this class of enzymes recognize their substrates in a sequence-independent, yet protein-dependent, manner. Interestingly, compared with previously determined structures of CpOGA D298N in complex with the TAB1-hOGAderived Ser-O-GlcNAc peptides [25] , the apolar extra γ -methyl group of the threonine residue appears to be unfavourably positioned near the Tyr 335 hydroxy group, perhaps explaining the reduction in affinity compared with the Ser-O-GlcNAc peptides. Nevertheless, CpOGA D298N appears to be able to bind both Ser-and Thr-O-GlcNAc peptides, enabling its potential use as a general detector of O-GlcNAc proteins.
We next investigated the suitability of CpOGA D298N as a far-Western blotting probe as outlined in Figure 1a . Human TAB1 was O-GlcNAcylated in vitro and probed with GST-fused CpOGA D298N in a Western blot. The fusion protein was detected using sheep anti-GST antibody in combination with a Li-Cor (an infra red (IR) Western blot detection system) -compatible antisheep secondary antibody. Specific signal was detected only with GST-CpOGA D298N (Figure 2a) . However, on performing the farWestern blotting with GST-CpOGA WT , (which hydrolyses the sugar, resulting in loss of binding), GST-CpOGA D401A or GSTCpOGA D298N, D401A (both deficient in O-GlcNAc protein binding [23] ; Supplementary Figure S3a) , as expected, the specific signal was not detected, establishing the suitability of CpOGA D298N for this purpose. When glycosylated TAB1 is pre-treated with CpOGA WT , thus deglycosylating it, the specific O-GlcNAcdependent signal is no longer detectable on a far-Western blot with GST-CpOGA D298N or with the CTD110.6/RL2 anti-O-GlcNAc antibodies (Figure 2a) . However, pre-treatment with CpOGA D298N , CpOGA D401A or CpOGA D298N,D401A did not lead to any change in the specific signal detected by GST-CpOGA D298N or with the CTD110.6/RL2 anti-O-GlcNAc antibodies, further confirming that these mutants are indeed inactive (Figure 2a) . Mammalian OGT is known to self-glycosylate [37] and hence we investigated auto-glycosylation of Drosophila OGT (DmOGT) using CpOGA D298N . HA-tagged DmOGT WT was embryonically overexpressed and immunoprecipitated using anti-HA antibody. O-GlcNAcylation of immunoprecipitated OGT was readily detected using CpOGA D298N far-Western blotting (Figure 2b ). The specificity of this reactivity was also determined by treating the immunoprecipitate with CpOGA WT , which considerably reduced the signal (Figure 2b) , thus demonstrating the utility of this farWestern blot approach in expanding the repertoire of detectable O-GlcNAc sites.
Next, we explored this approach using a more complex mammalian sample, HEK293 cell lysates. Specific OGlcNAcylated proteins were detected when far-Western blotting was performed using GST-CpOGA D298N , although GSTdependent reactivity is visible in the <50 kDa range (Figure 2c) . The specific signal of the >50 kDa bands diminished significantly when the lysates were pre-treated with CpOGA WT in order to remove the O-GlcNAc from proteins or on competing with 0.5 M GlcNAc (Figure 2c ). Additional controls including treatment of blots with GST, anti-GST antibody or the Li-Cor anti-sheep secondary antibody alone further established the specificity of O-GlcNAc detection with GST-CpOGA D298N (Supplementary Figure S3b) . The anti-O-GlcNAc antibody RL2 identified fewer bands (∼55 kDa, 100 kDa and > 130 kDa) as compared with GST-CpOGA D298N (Figure 2c ). Since the secretory Nglycosylation pathway also utilizes an N-GlcNAc(β1,4)GlcNAc core, cross-reactivity of CpOGA D298N to N-glycosylated proteins was tested. Lysates were treated with PNGase F or CpOGA WT to remove N-glycosylation or O-GlcNAcylation on proteins prior to the far-Western/Western blot analyses. Treatment of lysates with PNGase F distinctly reduced reactivity to ConA, a lectin routinely used to detect N-glycans (Supplementary Figure S3c) , but not the GST-CpOGA D298N -dependent signal ( Figure 2d ). As expected, pre-treatment with CpOGA WT significantly reduced detection by CpOGA D298N , establishing its specificity for nucleocytoplasmic O-GlcNAcylation (Figure 2d) . As with the in vitro experiments, specific signal is not detected when GST-CpOGA WT , GSTCpOGA D401A or GST-CpOGA D298N,D401A are used as far-Western blotting probes on HEK293 lysates (Supplementary Figure S3d) .
Finally, we used the far-Western blotting CpOGA D298N probe to investigate changes in the O-GlcNAc proteome in the context of Drosophila embryonic development. Specific O-GlcNAcylated proteins, spanning a large molecular mass range, were identified in 0-16 h Drosophila embryo lysates using this approach (Figure 3a) . Specificity of the detection was established by either competing the CpOGA D298N binding with 0.5 M GlcNAc or the loss of specific signal on pre-treatment of the lysate with CpOGA WT (Figures 3a and 3b) . The reactivity of CpOGA D298N was not altered when the embryo lysates were pre-treated with PNGase F, which did significantly reduce ConA binding (Supplementary Figure S3e) , confirming that CpOGA D298N specificity is towards OGlcNAc proteins and not N-glycosylated proteins in Drosophila embryo lysates. The utility of CpOGA D298N as a far-Western blotting probe was also compared with other O-GlcNAcylation detection methods. There is no specific signal detected at all with the CTD 110.6 antibody in Drosophila embryo lysates (Supplementary Figure S4a) . Similarly, UDP-GalNAz labelling of embryo lysates resulted in only marginally improved specific signals (Supplementary Figure S4b) .
To investigate changes in O-GlcNAcylation across Drosophila embryogenesis, embryos (growing at 25
• C) at the cellular blastoderm (2.5 h), germ band extension (5 h), germ band retraction (10 h) and dorsal closure (15 h) stages were collected and the far-Western blot experiment was performed. The number of O-GlcNAc proteins was the highest at the dorsal closure stage (Figure 3c ). Although there was progressive accumulation of O-GlcNAc on several proteins with developmental time, many proteins are O-GlcNAcylated at the germ band retraction stage or later (Figure 3c ). Whereas the overall O-GlcNAc profile detected using RL2 is comparable, numerous additional proteins are detected by the far-Western blot approach, (for instance, ∼70 kDa, 100 kDa, between 120 and 130 kDa and >170 kDa; Figure 3c ). These data reveal that, like protein phosphorylation, different developmental stages are associated with different O-GlcNAc proteomes offering opportunities for future identification of the proteins involved and probing the mechanistic developmental biology underlying these changes from larger-scale tissue samples.
Conclusions
The approach in the present study was to investigate changes in the O-GlcNAc proteome during Drosophila embryonic development, harnessing the O-GlcNAc-binding properties of CpOGA D298N . During the course of developing this tool, we have established that CpOGA D298N has higher affinity for Ser-O-GlcNAc than for Thr-O-GlcNAc peptides. A crystal structure of a Thr-O-GlcNAc peptide, in complex with CpOGA D298N , has revealed that the position of the additional threonine γ -methyl is unfavourable, possibly leading to the lower affinity of CpOGA D298N for Thr-O-GlcNAc peptides. Whether this difference in affinities of CpOGA D298N towards Ser-compared with Thr-O-GlcNAc would lead to differential catalytic rates of the active enzyme or translates to physiological consequence(s) remains to be explored.
We have shown in the present study that the OGlcNAc proteome during Drosophila embryonic development is dynamic. Changes in the O-GlcNAc proteome during Xenopus embryogenesis have been investigated using anti-O-GlcNAc RL2 antibody [38] . During Xenopus embryogenesis, the number of different that are O-GlcNAcylated proteins seems to be constant, with the most obvious changes being the extent of their OGlcNAc levels, possibly because of the restricted specificity of the RL2 antibody. However, during Drosophila embryonic development, in addition to quantitative changes in O-GlcNAc levels on particular proteins, the number of proteins that are O-GlcNAcylated is also dynamic. A recent report identified polyhomoeotic (Ph), a polycomb group protein, as the major substrate for OGT during Drosophila development [39] . However, the present study demonstrates that there are multiple OGT substrates during Drosophila embryogenesis. Given that sxc mutants lacking maternal OGT are late embryonic lethals, it will be feasible to identify the O-GlcNAcylated proteins during Drosophila embryogenesis and investigate the significance of their O-GlcNAc status in this model. Reduced O-GlcNAcylation of proteins (other than Ph) could possibly lead to non-lethal subtler phenotypes that could be investigated during early embryogenesis. The impetus of this approach would be to understand the role of O-GlcNAcylation on sites conserved in mammalian orthologues using the strength of the Drosophila genetic model. 
